SG11201407114YA - Novel dosage and formulation - Google Patents
Novel dosage and formulationInfo
- Publication number
- SG11201407114YA SG11201407114YA SG11201407114YA SG11201407114YA SG11201407114YA SG 11201407114Y A SG11201407114Y A SG 11201407114YA SG 11201407114Y A SG11201407114Y A SG 11201407114YA SG 11201407114Y A SG11201407114Y A SG 11201407114YA SG 11201407114Y A SG11201407114Y A SG 11201407114YA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- barcelona
- aclidinium
- llobregat
- laurea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0038—Cutting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0051—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0086—Inhalation chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/042—Force radial
- F04C2270/0421—Controlled or regulated
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 28 November 2013 (28.11.2013) WIPOIPCT (10) International Publication Number WO 2013/175013 A1 (51) International Patent Classification: A61K31/46 (2006.01) A61P11/08 (2006.01) A61M15/00 (2006.01) A61K31/573 (2006.01) A61P11/06 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: (30) Priority Data: 12382211.6 61/654,224 61/779,578 PCT/EP2013/060808 24 May 2013 (24.05.2013) English English EP US US 25 May 2012 (25.05.2012) 1 June 2012 (01.06.2012) 13 March 2013 (13.03.2013) (71) Applicant: ALMIRALL, S.A. [ES/ES]; Ronda del Gener al Mitre 151, E-08022 Barcelona (ES). (72) Inventors: LAMARCA CASADO, Rosa; C/ Laurea Miro 408-410, Sant Feliu de Llobregat, E-08980 Barcelona (ES). DE MIQUEL SERRA, Gonzalo; C/ Laurea Miro 408-410, Sant Feliu de Llobregat, E-08980 Barcelona (ES). (74) Agent: SRINIVASAN, Ravi Chandran; J A Kemp & Co., 14 South Square, Gray's Inn, London Greater London WC1R 5JJ (GB). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) i-H o i> i-H o CJ (54) Title: NOVEL DOSAGE AND FORMULATION (57) Abstract: A pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutic - ally acceptable salt in admixture with pharmaceutically acceptable a dry powder carrier, providing a delivered dose of aclidinium equivalent to about 322 micrograms aclidinium free base.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20120382211 EP2666465A1 (en) | 2012-05-25 | 2012-05-25 | Novel dosage and formulation |
US201261654224P | 2012-06-01 | 2012-06-01 | |
US201361779578P | 2013-03-13 | 2013-03-13 | |
PCT/EP2013/060808 WO2013175013A1 (en) | 2012-05-25 | 2013-05-24 | Novel dosage and formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201407114YA true SG11201407114YA (en) | 2014-12-30 |
Family
ID=46210186
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201609244PA SG10201609244PA (en) | 2012-05-25 | 2013-05-24 | Novel dosage and formulation |
SG11201407114YA SG11201407114YA (en) | 2012-05-25 | 2013-05-24 | Novel dosage and formulation |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201609244PA SG10201609244PA (en) | 2012-05-25 | 2013-05-24 | Novel dosage and formulation |
Country Status (23)
Country | Link |
---|---|
US (2) | US20150118312A1 (en) |
EP (2) | EP2666465A1 (en) |
JP (1) | JP2015517560A (en) |
KR (1) | KR20150010757A (en) |
CN (1) | CN104349776A (en) |
AR (1) | AR091161A1 (en) |
AU (1) | AU2013265167B2 (en) |
CA (1) | CA2871357A1 (en) |
CL (1) | CL2014003211A1 (en) |
CO (1) | CO7200262A2 (en) |
CR (1) | CR20140536A (en) |
DO (1) | DOP2014000269A (en) |
EA (1) | EA201401309A1 (en) |
HK (1) | HK1203050A1 (en) |
IL (1) | IL235830A0 (en) |
IN (1) | IN2014DN08421A (en) |
MD (1) | MD20140131A2 (en) |
MX (1) | MX2014014041A (en) |
PE (1) | PE20142441A1 (en) |
PH (1) | PH12014502619A1 (en) |
SG (2) | SG10201609244PA (en) |
UY (1) | UY34829A (en) |
WO (1) | WO2013175013A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2165768B1 (en) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
JP6214640B2 (en) * | 2012-06-01 | 2017-10-18 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Method and system for selecting frequency of arterial blood gas test for newborns |
CN105078932A (en) * | 2015-09-06 | 2015-11-25 | 北京东方百泰生物科技有限公司 | Method for increasing fine particle proportion of medicinal preparation and preparation |
CN107823193B (en) * | 2017-11-16 | 2021-02-05 | 广州迈达康医药科技有限公司 | Aclidinium bromide inhalation type powder aerosol and preparation method thereof |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT7920688V0 (en) | 1979-02-05 | 1979-02-05 | Chiesi Paolo Parma | INHALER FOR PULVERULENT MEDICINAL SUBSTANCES, WITH COMBINED DOSER FUNCTION. |
EP0069715B1 (en) | 1981-07-08 | 1986-11-05 | Aktiebolaget Draco | Powder inhalator |
US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
FI69963C (en) | 1984-10-04 | 1986-09-12 | Orion Yhtymae Oy | DOSERINGSANORDNING |
DE3927170A1 (en) | 1989-08-17 | 1991-02-21 | Boehringer Ingelheim Kg | INHALATOR |
IT1237118B (en) | 1989-10-27 | 1993-05-18 | Miat Spa | MULTI-DOSE INHALER FOR POWDER DRUGS. |
US5201308A (en) | 1990-02-14 | 1993-04-13 | Newhouse Michael T | Powder inhaler |
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
WO1992003175A1 (en) | 1990-08-11 | 1992-03-05 | Fisons Plc | Inhalation device |
DE4027391A1 (en) | 1990-08-30 | 1992-03-12 | Boehringer Ingelheim Kg | GAS-FREE INHALATION DEVICE |
DK0503031T3 (en) | 1990-09-26 | 1999-01-04 | Pharmachemie Bv | Inhalator with a reservoir for multiple doses of a material to be inhaled |
GB9026025D0 (en) | 1990-11-29 | 1991-01-16 | Boehringer Ingelheim Kg | Inhalation device |
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
DE4239402A1 (en) | 1992-11-24 | 1994-05-26 | Bayer Ag | Multiple dosage powder inhaler - has acceleration channel and dwell chamber for uniformly high drug dispersion |
CZ287848B6 (en) | 1992-12-18 | 2001-02-14 | Schering Corp | Inhalator of powder substances |
DE69617431T2 (en) | 1995-06-21 | 2002-08-01 | Asta Medica Ag | MEDICINE POWDER CARTRIDGE WITH INTEGRATED DOSING DEVICE AND POWDER INHALATOR |
ES2165768B1 (en) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
DE10129703A1 (en) | 2001-06-22 | 2003-01-02 | Sofotec Gmbh & Co Kg | Atomizing system for a powder mixture and method for dry powder inhalers |
ITMI20010357U1 (en) | 2001-06-28 | 2002-12-30 | Plastiape Spa | INHALER DEVICE |
DE10202940A1 (en) | 2002-01-24 | 2003-07-31 | Sofotec Gmbh & Co Kg | Cartridge for a powder inhaler |
ES2195785B1 (en) | 2002-05-16 | 2005-03-16 | Almirall Prodesfarma, S.A. | NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA. |
ES2211344B1 (en) | 2002-12-26 | 2005-10-01 | Almirall Prodesfarma, S.A. | NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA. |
PL1651270T3 (en) * | 2003-07-29 | 2007-06-29 | Boehringer Ingelheim Int | Medicaments for inhalation comprising betamimetics and an anticholinergic |
ES2232306B1 (en) | 2003-11-10 | 2006-08-01 | Almirall Prodesfarma, S.A. | NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA. |
GB0410712D0 (en) | 2004-05-13 | 2004-06-16 | Novartis Ag | Organic compounds |
ES2251866B1 (en) | 2004-06-18 | 2007-06-16 | Laboratorios Almirall S.A. | NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA. |
ES2251867B1 (en) | 2004-06-21 | 2007-06-16 | Laboratorios Almirall S.A. | NEW DERIVATIVES OF PIRIDAZIN-3 (2H) -ONA. |
UA93031C2 (en) | 2004-07-16 | 2011-01-10 | Алміралл, С.А. | inhaler for powdered medicaments, pharmaceutical powder cartridge for use with the inhaler and method for inhaler use |
ES2298049B1 (en) | 2006-07-21 | 2009-10-20 | Laboratorios Almirall S.A. | PROCEDURE FOR MANUFACTURING BROMIDE OF 3 (R) - (2-HIDROXI-2,2-DITIEN-2-ILACETOXI) -1- (3-PHENOXIPROPIL) -1-AZONIABICICLO (2.2.2) OCTANO. |
EP2100598A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100599A1 (en) * | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
TR201811349T4 (en) * | 2010-04-01 | 2018-09-21 | Chiesi Farm Spa | PROCESS FOR PREPARATION OF DRY POWDER CARRIER PARTICULARS FOR INHALATION. |
-
2012
- 2012-05-25 EP EP20120382211 patent/EP2666465A1/en not_active Withdrawn
-
2013
- 2013-05-24 PE PE2014002022A patent/PE20142441A1/en not_active Application Discontinuation
- 2013-05-24 EA EA201401309A patent/EA201401309A1/en unknown
- 2013-05-24 JP JP2015513219A patent/JP2015517560A/en active Pending
- 2013-05-24 SG SG10201609244PA patent/SG10201609244PA/en unknown
- 2013-05-24 US US14/403,220 patent/US20150118312A1/en not_active Abandoned
- 2013-05-24 IN IN8421DEN2014 patent/IN2014DN08421A/en unknown
- 2013-05-24 AU AU2013265167A patent/AU2013265167B2/en not_active Ceased
- 2013-05-24 MD MDA20140131A patent/MD20140131A2/en not_active Application Discontinuation
- 2013-05-24 AR ARP130101828 patent/AR091161A1/en unknown
- 2013-05-24 CN CN201380027441.4A patent/CN104349776A/en active Pending
- 2013-05-24 WO PCT/EP2013/060808 patent/WO2013175013A1/en active Application Filing
- 2013-05-24 MX MX2014014041A patent/MX2014014041A/en unknown
- 2013-05-24 UY UY34829A patent/UY34829A/en not_active Application Discontinuation
- 2013-05-24 EP EP13725154.2A patent/EP2854808A1/en not_active Withdrawn
- 2013-05-24 KR KR1020147032690A patent/KR20150010757A/en not_active Application Discontinuation
- 2013-05-24 SG SG11201407114YA patent/SG11201407114YA/en unknown
- 2013-05-24 CA CA2871357A patent/CA2871357A1/en not_active Abandoned
-
2014
- 2014-11-20 IL IL235830A patent/IL235830A0/en unknown
- 2014-11-21 CR CR20140536A patent/CR20140536A/en unknown
- 2014-11-24 CO CO14258287A patent/CO7200262A2/en unknown
- 2014-11-24 PH PH12014502619A patent/PH12014502619A1/en unknown
- 2014-11-25 CL CL2014003211A patent/CL2014003211A1/en unknown
- 2014-11-25 DO DO2014000269A patent/DOP2014000269A/en unknown
-
2015
- 2015-04-13 HK HK15103573.2A patent/HK1203050A1/en unknown
-
2017
- 2017-01-19 US US15/409,741 patent/US20170128426A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20170128426A1 (en) | 2017-05-11 |
DOP2014000269A (en) | 2015-02-27 |
IL235830A0 (en) | 2015-01-29 |
US20150118312A1 (en) | 2015-04-30 |
CL2014003211A1 (en) | 2015-06-05 |
AU2013265167B2 (en) | 2017-08-17 |
EP2854808A1 (en) | 2015-04-08 |
PH12014502619A1 (en) | 2015-01-21 |
AR091161A1 (en) | 2015-01-14 |
EP2666465A1 (en) | 2013-11-27 |
EA201401309A1 (en) | 2015-06-30 |
IN2014DN08421A (en) | 2015-05-08 |
WO2013175013A1 (en) | 2013-11-28 |
AU2013265167A1 (en) | 2014-10-30 |
CA2871357A1 (en) | 2013-11-28 |
KR20150010757A (en) | 2015-01-28 |
PE20142441A1 (en) | 2015-01-17 |
MX2014014041A (en) | 2015-02-12 |
CN104349776A (en) | 2015-02-11 |
UY34829A (en) | 2013-12-31 |
SG10201609244PA (en) | 2016-12-29 |
JP2015517560A (en) | 2015-06-22 |
HK1203050A1 (en) | 2015-10-16 |
CR20140536A (en) | 2014-12-15 |
CO7200262A2 (en) | 2015-02-27 |
MD20140131A2 (en) | 2015-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201407114YA (en) | Novel dosage and formulation | |
SG11201909963YA (en) | Methods for treating dravet syndrome | |
SG11201909325RA (en) | 2-amino-quinoline derivatives | |
SG11201810423XA (en) | Pd-1 / pd-l1 inhibitors for cancer treatment | |
SG11201807708SA (en) | Estrogen receptor modulators | |
SG11201808682XA (en) | Silicone atoms containing ivacaftor analogues | |
SG11201407110QA (en) | Novel dosage form and formulation of abediterol | |
SG11201810628XA (en) | Nasal pharmaceutical compositions with a porous excipient | |
SG11201810280YA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
SG11201808237UA (en) | Substituted indole compound derivatives as dengue viral replication inhibitors | |
SG11201805645QA (en) | Lsd1 inhibitors | |
SG11201809799WA (en) | Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions | |
SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
SG11201808138YA (en) | Substituted indole derivatives as dengue viral replication inhibitors | |
SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
SG11201809751XA (en) | Egfr inhibitor compounds | |
SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
SG11201804050QA (en) | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | |
SG11201900551WA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
SG11201804048WA (en) | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | |
SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof | |
SG11201408292YA (en) | Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same | |
SG11201402986RA (en) | Kinase inhibitors | |
SG11201908691PA (en) | Compounds and methods for the treatment of parasitic diseases | |
SG11201900043TA (en) | Antibody formulations |